Correlations of intratumoral T cell (ITTC) levels with clinicopathological variables, microsatellite status and major histocompatibility complex (MHC) expression
| ITTC | p Value | |||
| Low | High | |||
| Sex | Male | 76 (62.8%) | 134 (57.3%) | 0.314 |
| Female | 45 (37.2%) | 100 (42.7%) | ||
| Grade | Well | 9 (7.4%) | 13 (5.6%) | 0.883 |
| Moderate | 91 (75.2%) | 177 (75.6%) | ||
| Poor | 18 (14.9%) | 39 (16.1%) | ||
| TNM stage | I | 7 (5.8%) | 51 (21.8%) | 0.003* |
| II | 54 (44.6%) | 80 (34.2%) | ||
| III | 36 (30.5%) | 82 (35%) | ||
| IV | 20 (16.5%) | 19 (8.1%) | ||
| Vascular invasion | Absent | 49 (56.3%) | 127 (69.4%) | 0.041† |
| Present | 38 (43.7%) | 56 (30.6%) | ||
| Site of primary tumour | Colon | 68 (63%) | 108 (50.7%) | 0.044† |
| Rectum | 40 (37%) | 105 (49.3%) | ||
| MHC class I | Negative | 26 (21.5%) | 23 (9.9%) | 0.0002 |
| Weak | 56 (46.3%) | 86 (36.9%) | ||
| Strong | 39 (32.2%) | 124 (53.2%) | ||
| Microsatellite instability | MSI | 26 (22%) | 61 (27.5%) | 0.274 |
| MSS | 92 (78%) | 161 (72.5%) | ||